Global trial seeks to extend lives in Tough-to-Treat bile duct cancer

NCT ID NCT03875235

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This large, international study tested whether adding an immunotherapy drug (durvalumab) to standard chemotherapy helps people with advanced bile duct cancer live longer. It involved 810 patients who had not received prior treatment for their advanced disease. The main goal was to see if the new combination improved overall survival compared to chemotherapy alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Los Angeles, California, 90027, United States
Research Site

Orange, California, 92868, United States
Research Site

Washington D.C., District of Columbia, 20007, United States
Research Site

Fort Myers, Florida, 33905, United States
Research Site

St. Petersburg, Florida, 33705, United States
Research Site

Westwood, Kansas, 66205, United States
Research Site

Louisville, Kentucky, 40202, United States
Research Site

Burlington, Massachusetts, 01805, United States
Research Site

St Louis, Missouri, 63110, United States
Research Site

Chapel Hill, North Carolina, 27514, United States
Research Site

Portland, Oregon, 97213, United States
Research Site

Philadelphia, Pennsylvania, 19111, United States
Research Site

Chattanooga, Tennessee, 37404, United States
Research Site

Nashville, Tennessee, 37203, United States
Research Site

Seattle, Washington, 98109, United States
Research Site

Buenos Aires, C1118AAT, Argentina
Research Site

CABA, C1012AAR, Argentina
Research Site

CABA, C1019ABS, Argentina
Research Site

Ciudad de Buenos Aires, 1280, Argentina
Research Site

Ciudad de Buenos Aires, C1426ANZ, Argentina
Research Site

Rosario, 2000, Argentina
Research Site

San Salvador de Jujuy, 4600, Argentina
Research Site

Burgas, 8000, Bulgaria
Research Site

Sofia, 1330, Bulgaria
Research Site

Sofia, 1407, Bulgaria
Research Site

Sofia, 1606, Bulgaria
Research Site

Varna, 9010, Bulgaria
Research Site

Santiago, 7630370, Chile
Research Site

Temuco, 4810218, Chile
Research Site

Baoding, 071000, China
Research Site

Beijing, 100021, China
Research Site

Beijing, 100142, China
Research Site

Bengbu, 233004, China
Research Site

Chongqing, 400038, China
Research Site

Foshan, 528000, China
Research Site

Guangzhou, 510062, China
Research Site

Hangzhou, 310003, China
Research Site

Hangzhou, 310009, China
Research Site

Harbin, 150081, China
Research Site

Hefei, 230001, China
Research Site

Hefei, 230601, China
Research Site

Jinan, 250014, China
Research Site

Nanchang, 330006, China
Research Site

Nanjing, 210002, China
Research Site

Shandong, China
Research Site

Shanghai, 200032, China
Research Site

Shenyang, 100003, China
Research Site

Suzhou, 215004, China
Research Site

Xi'an, 710061, China
Research Site

Zhengzhou, 450008, China
Research Site

Zhuhai, 519000, China
Research Site

Clichy, 92210, France
Research Site

Dijon, 21079, France
Research Site

Montpellier, 34295, France
Research Site

Nice, 6189, France
Research Site

Paris, 75571, France
Research Site

Pessac, 33604, France
Research Site

Poitiers, 86021, France
Research Site

Hong Kong, 00000, Hong Kong
Research Site

Hong Kong, 150001, Hong Kong
Research Site

Hong Kong, Hong Kong
Research Site

Kowloon, Hong Kong
Research Site

Gūrgaon, 122001, India
Research Site

Kolkata, 700160, India
Research Site

Mumbai, 400012, India
Research Site

New Delhi, 110085, India
Research Site

Faenza, 48018, Italy
Research Site

Florence, 50134, Italy
Research Site

Milan, 20132, Italy
Research Site

Naples, 80131, Italy
Research Site

Roma, 00168, Italy
Research Site

Verona, 37134, Italy
Research Site

Chūōku, 104-0045, Japan
Research Site

Kashiwa, 227-8577, Japan
Research Site

Kitaadachi-gun, 362-0806, Japan
Research Site

Mitaka-shi, 181-8611, Japan
Research Site

Osaka, 541-8567, Japan
Research Site

Suita-shi, 565-0871, Japan
Research Site

Wakayama, 641-8510, Japan
Research Site

Yokohama, 241-8515, Japan
Research Site

Gdansk, 80-952, Poland
Research Site

Lodz, 93-513, Poland
Research Site

Olsztyn, 10-228, Poland
Research Site

Poznan, 60-780, Poland
Research Site

Warsaw, 02-106, Poland
Research Site

Wroclaw, 50-556, Poland
Research Site

Barnaul, 656049, Russia
Research Site

Kostroma, 156005, Russia
Research Site

Moscow, 115478, Russia
Research Site

Moscow, 121467, Russia
Research Site

Moscow, 125284, Russia
Research Site

Omsk, 644033, Russia
Research Site

Saint Petersburg, 197022, Russia
Research Site

Saint Petersburg, 197758, Russia
Research Site

Seongnam-si, 13620, South Korea
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 06351, South Korea
Research Site

Seoul, 06591, South Korea
Research Site

Seoul, 152-703, South Korea
Research Site

Chiayi City, 613, Taiwan
Research Site

Kaohsiung City, 82445, Taiwan
Research Site

Kaohsiung City, 83301, Taiwan
Research Site

Taichung, 40705, Taiwan
Research Site

Tainan, 704, Taiwan
Research Site

Taipei, 10050, Taiwan
Research Site

Taipei, 11217, Taiwan
Research Site

Taoyuan District, 333, Taiwan
Research Site

Bangkok, 10330, Thailand
Research Site

Bangkok, 10400, Thailand
Research Site

Hat Yai, 90110, Thailand
Research Site

Khon Kaen, 40002, Thailand
Research Site

Muang, 50200, Thailand
Research Site

Si Sa Ket, 33000, Thailand
Research Site

Ankara, 06100, Turkey (Türkiye)
Research Site

Istanbul, 34030, Turkey (Türkiye)
Research Site

Izmir, 35100, Turkey (Türkiye)
Research Site

Mersin, 33110, Turkey (Türkiye)
Research Site

Bristol, BS2 8ED, United Kingdom
Research Site

Cambridge, CB2 0QQ, United Kingdom
Research Site

London, NW3 2QG, United Kingdom
Research Site

London, W12 0NN, United Kingdom
Research Site

Manchester, M20 4BX, United Kingdom
Research Site

Oxford, OX3 7LE, United Kingdom
Research Site

Romford, RM7 0AG, United Kingdom
Research Site

Sheffield, S10 2SJ, United Kingdom

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT NEOPLASMS